We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMEI
7001
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
-2,271
Closed -$48K
BCRH
7002
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
-30
Closed
AYR
7003
PUT
DELISTED
Aircastle Ltd
AYR
-100
Closed -$2K
INAP
7004
DELISTED
Internap Corporation
INAP
$0 ﹤0.01%
+3
New +$5
SITO
7005
DELISTED
SITO MOBILE, LTD
SITO
$0 ﹤0.01%
+78
New +$41
FOMX
7006
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$0 ﹤0.01%
39
-1,088
-97% -$3.46K
CSS
7007
DELISTED
CSS Industries, Inc.
CSS
$0 ﹤0.01%
1
-309
-100% -$1.39K
MNI
7008
DELISTED
The McClatchy Company Class A Common Stock
MNI
$0 ﹤0.01%
+20
New +$30
BLPH
7009
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-24
Closed
CFRX
7010
DELISTED
ContraFect Corporation
CFRX
0
GNMX
7011
DELISTED
Aevi Genomic Medicine Inc
GNMX
$0 ﹤0.01%
135
-17
-11% -$2
WTRU
7012
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
-365,500
Closed -$22.1M
JASN
7013
DELISTED
Jason Industries, Inc.
JASN
$0 ﹤0.01%
55
+36
+189% +$9
MLNT
7014
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$0 ﹤0.01%
13
-84
-87% -$204
TRCB
7015
DELISTED
Two River Bancorp
TRCB
-3
Closed
BKJ
7016
DELISTED
Bancorp of New Jersey, Inc.
BKJ
-44
Closed -$1K
EEI
7017
DELISTED
Ecology and Environment
EEI
-86
Closed -$1K
PVTL
7018
DELISTED
Pivotal Software, Inc.
PVTL
-5,200
Closed -$78K
CARB
7019
CALL
DELISTED
Carbonite Inc
CARB
-1,300
Closed -$20K
CARB
7020
DELISTED
Carbonite Inc
CARB
-16,323
Closed -$253K
EFBI
7021
DELISTED
Eagle Financial Bancorp, Inc. Common Stock
EFBI
-7
Closed
CRZO
7022
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
-4,000
Closed -$34K
CRZO
7023
DELISTED
Carrizo Oil & Gas Inc
CRZO
-783,847
Closed -$6.73M
CRZO
7024
PUT
DELISTED
Carrizo Oil & Gas Inc
CRZO
-3,500
Closed -$30K
HOS
7025
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$0 ﹤0.01%
49
-6,631
-99% -$3.4K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.